Collectively, these findings suggest that METTL3 contributes to COPD pathogenesis through the regulation of EMT, inflammatory responses, and autophagy, highlighting its potential as a novel therapeutic target in chronic airway diseases. Here, METTL3 is linked to chronic obstructive pulmonary disease.